Hans-Peter Rudolf

Hans-Peter Rudolf

Director/Board Member at Phosphate Therapeutics Ltd.

58 year
Commercial Services
Health Technology
Consumer Services

Profile

Hans-Peter Rudolf is currently a Director at Phosphate Therapeutics Ltd.
He previously worked as an Audit Partner at Ernst & Young LLP from 2003 to 2006, and as a Partner at Ernst & Young AG.
He was also the Head-Group Accounting at Bellefontaine Investments AG from 2011 to 2017, and an Audit Partner at Crowe LLP from 2006 to 2010.
From 2017 to 2020, he served as the Chief Financial Officer at Vicarius Pharma AG.
Rudolf holds an undergraduate degree from Cleveland State University and the University of Zurich.
He is currently the Chief Financial Officer at Shield Therapeutics Plc.

Hans-Peter Rudolf active positions

CompaniesPositionStart
Director/Board Member 2021-05-11
All active positions of Hans-Peter Rudolf

Former positions of Hans-Peter Rudolf

CompaniesPositionEnd
SHIELD THERAPEUTICS PLC Director of Finance/CFO 2023-10-19
Director of Finance/CFO 2020-03-31
Comptroller/Controller/Auditor 2017-03-31
Corporate Officer/Principal 2010-11-30
Corporate Officer/Principal 2006-06-30
See the detail of Hans-Peter Rudolf's experience

Training of Hans-Peter Rudolf

Cleveland State University Undergraduate Degree
University of Zurich Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hans-Peter Rudolf's experience

Connections

100 +

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
SHIELD THERAPEUTICS PLC

Health Technology

Private companies6

Health Technology

Commercial Services

Commercial Services

Commercial Services

Finance

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. Hans-Peter Rudolf